Robertson Stephens Wealth Management, LLC
Position in CUE — Cue Biopharma, Inc.
CIK 1767307
San Francisco, CA
Position in CUE
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$110,055
-$35,887 QoQ
Shares Held
478,500
0.0% QoQ
Ownership
11.8%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#7
of 53 holders
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in CUE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Robertson Stephens Wealth Management, LLC holds $3,118,849 across 12 Biotechnology names. CUE ranks #6 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,836 | $938,347 | |
| 2 | MRNA |
Moderna, Inc.
|
14,855 | $754,634 | |
| 3 | INCY |
Incyte Corp
|
6,683 | $629,003 | |
| 4 | SRPT |
Sarepta Therapeutics, Inc.
|
11,023 | $239,860 | |
| 5 | RLMD |
Relmada Therapeutics, Inc.
|
25,000 | $174,000 | |
| 6 | CUE |
Cue Biopharma, Inc.
This page
|
478,500 | $110,055 | |
| 7 | ATAI |
AtaiBeckley Inc.
|
28,297 | $100,171 | |
| 8 | ACHV |
Achieve Life Sciences, Inc.
|
20,000 | $58,800 |
All Filings in CUE
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $110,055 | 478,500 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $145,942 | 478,500 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $344,041 | 478,500 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $326,337 | 478,500 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $435,913 | 478,500 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $521,565 | 478,500 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $362,224 | 478,500 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $593,340 | 478,500 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $904,365 | 478,500 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,263,240 | 478,500 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $1,100,550 | 478,500 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,746,525 | 478,500 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $1,708,245 | 478,500 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,363,725 | 478,500 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,067,055 | 478,500 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,191,465 | 478,500 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,335,080 | 478,500 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $5,411,835 | 478,500 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $6,971,745 | 478,500 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $5,574,525 | 478,500 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $5,837,700 | 478,500 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $6,054,840 | 484,000 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $7,284,200 | 484,000 | Shares | Sole | 2020-11-10 | |
| No filing history on record for this holder in this stock. | ||||||